UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Sensory processing in autism spectrum disorders and Fragile X syndrome—From the clinic to animal models

Neuroscience and biobehavioral reviews, 2017-05, Vol.76 (Pt B), p.235-253

2017

Volltextzugriff (PDF)

Cross-sectional associations between adaptive functioning and social cognitive and neurocognitive functions in adolescents with first-episode, early-onset schizophrenia spectrum disorders

Development and psychopathology, 2024-02, Vol.36 (1), p.208-218

2024

Volltextzugriff (PDF)

Selective attention and mismatch negativity in antipsychotic-naïve, first-episode schizophrenia patients before and after 6 months of antipsychotic monotherapy

Psychological medicine, 2017-09, Vol.47 (12), p.2155-2165

2017

Volltextzugriff (PDF)

Mismatch negativity and P3a amplitude in young adolescents with first-episode psychosis: a comparison with ADHD

Psychological medicine, 2017-01, Vol.47 (2), p.377-388

2017

Volltextzugriff (PDF)

Overlapping and disease specific trait, response, and reflection impulsivity in adolescents with first-episode schizophrenia spectrum disorders or attention-deficit/hyperactivity disorder

Psychological medicine, 2018-03, Vol.48 (4), p.604-616

2018

Volltextzugriff (PDF)

Attenuated mismatch negativity in patients with first-episode antipsychotic-naive schizophrenia using a source-resolved method

NeuroImage clinical, 2019-01, Vol.22, p.101760-101760, Article 101760

2019

Volltextzugriff (PDF)

Two subgroups of antipsychotic-naive, first-episode schizophrenia patients identified with a Gaussian mixture model on cognition and electrophysiology

Translational psychiatry, 2017-04, Vol.7 (4), p.e1087-e1087

2017

Volltextzugriff (PDF)

A single high dose of escitalopram increases mismatch negativity without affecting processing negativity or P300 amplitude in healthy volunteers

Journal of psychopharmacology (Oxford), 2010-08, Vol.24 (8), p.1183-1192

2010

Volltextzugriff (PDF)

Adolescents at ultra-high risk for psychosis: Long-term outcome of individuals who recover from their at-risk state

European neuropsychopharmacology, 2014-06, Vol.24 (6), p.865-873

2014

Volltextzugriff (PDF)

The influence of impaired processing speed on cognition in first-episode antipsychotic-naïve schizophrenic patients

European psychiatry, 2013-08, Vol.28 (6), p.332-339

2013

Volltextzugriff (PDF)

Testing a decades’ old assumption: are individuals with lower sensory gating indeed more easily distracted?

Psychiatry research, 2017-09, Vol.255, p.387-393

2017

Volltextzugriff (PDF)

Neocortical serotonin2A receptor binding predicts quetiapine associated weight gain in antipsychotic-naive first-episode schizophrenia patients

The international journal of neuropsychopharmacology, 2014-11, Vol.17 (11), p.1729-1736

2014

Volltextzugriff (PDF)

Macroscale EEG characteristics in antipsychotic-naïve patients with first-episode psychosis and healthy controls

Schizophrenia (Heidelberg, Germany), 2023-01, Vol.9 (1), p.5-5, Article 5

2023

Volltextzugriff (PDF)

Preference for biological motion is reduced in ASD: implications for clinical trials and the search for biomarkers

Molecular autism, 2021-12, Vol.12 (1), p.74-13, Article 74

2021

Volltextzugriff (PDF)

Functional connectivity during cognitive control in children with autism spectrum disorder: an independent component analysis

Journal of Neural Transmission, 2014-09, Vol.121 (9), p.1145-1155

2014

Volltextzugriff (PDF)

S.07.01 Developmental differences in higher-order resting-state networks in autism spectrum disorder

European neuropsychopharmacology, 2014-10, Vol.24, p.S118-S118

2014

Volltextzugriff (PDF)

S.12.03 Gender-dependent sensory gating in antipsychotic naive first-episode schizophrenia patients

European neuropsychopharmacology, 2011, Vol.21, p.S204-S204

2011

Volltextzugriff (PDF)

P.2.19 Effects of clonidine on MMN and P3a amplitude in schizophrenia patients on stable medication

European neuropsychopharmacology, 2019, Vol.29, p.S668-S669

2019

Volltextzugriff (PDF)

The effects of a sub-anaesthetic dose of ketamine on human selective attention

Neuropsychopharmacology (New York, N.Y.), 2000-03, Vol.22 (3), p.293-302

2000

Volltextzugriff (PDF)

P.0282 Evidence for steroid hormone associations with key brain markers of information filtering in healthy women

European neuropsychopharmacology, 2021-12, Vol.53, p.S203-S204

2021

Volltextzugriff (PDF)

The effects of low dose ketamine on sensory gating, neuroendocrine secretion and behavior in healthy human subjects

Psychopharmacologia, 1998-06, Vol.137 (3), p.271-281

1998

Volltextzugriff (PDF)

Stratifying the autistic phenotype using electrophysiological indices of social perception

Science translational medicine, 2022-08, Vol.14 (658)

2022

Volltextzugriff (PDF)

P.130 Bumetanide versus placebo for core symptoms of autism spectrum disorder at 91 days (BAMBI): a single-centre, double-blinded, patient-randomized, placebo-controlled, phase-2-trial

European neuropsychopharmacology, 2020-11, Vol.40, p.S80-S81

2020

Volltextzugriff (PDF)

Resting state-EEG connectivity and machine learning: towards improved treatment response predictions in psychiatry

Tijdschrift voor psychiatrie, 2023, Vol.65 (10), p.637-640

2023

Volltextzugriff (PDF)

P.4.11 Bumetanide in Autism Medication and Biomarker (BAMBI) study: Medication response profiles

European neuropsychopharmacology, 2019, Vol.29, p.S708-S709

2019

Volltextzugriff (PDF)

1 – 25 von 188

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(161)
Mit Volltextzugriff
(154)

Publikationsform

Artikel
(171)
Buchkapitel
(14)
Berichte
(2)
Bücher
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Sensory processing in autism spectrum disorders and Fragile X syndrome—From the clinic to animal models

Cross-sectional associations between adaptive functioning and social cognitive and neurocognitive functions in adolescents with first-episode, early-onset schizophrenia spectrum disorders

Selective attention and mismatch negativity in antipsychotic-naïve, first-episode schizophrenia patients before and after 6 months of antipsychotic monotherapy

Mismatch negativity and P3a amplitude in young adolescents with first-episode psychosis: a comparison with ADHD

Overlapping and disease specific trait, response, and reflection impulsivity in adolescents with first-episode schizophrenia spectrum disorders or attention-deficit/hyperactivity disorder

Attenuated mismatch negativity in patients with first-episode antipsychotic-naive schizophrenia using a source-resolved method

Two subgroups of antipsychotic-naive, first-episode schizophrenia patients identified with a Gaussian mixture model on cognition and electrophysiology

A single high dose of escitalopram increases mismatch negativity without affecting processing negativity or P300 amplitude in healthy volunteers

Adolescents at ultra-high risk for psychosis: Long-term outcome of individuals who recover from their at-risk state

The influence of impaired processing speed on cognition in first-episode antipsychotic-naïve schizophrenic patients

Testing a decades’ old assumption: are individuals with lower sensory gating indeed more easily distracted?

Neocortical serotonin2A receptor binding predicts quetiapine associated weight gain in antipsychotic-naive first-episode schizophrenia patients

Macroscale EEG characteristics in antipsychotic-naïve patients with first-episode psychosis and healthy controls

Preference for biological motion is reduced in ASD: implications for clinical trials and the search for biomarkers

Functional connectivity during cognitive control in children with autism spectrum disorder: an independent component analysis

S.07.01 Developmental differences in higher-order resting-state networks in autism spectrum disorder

S.12.03 Gender-dependent sensory gating in antipsychotic naive first-episode schizophrenia patients

P.2.19 Effects of clonidine on MMN and P3a amplitude in schizophrenia patients on stable medication

The effects of a sub-anaesthetic dose of ketamine on human selective attention

P.0282 Evidence for steroid hormone associations with key brain markers of information filtering in healthy women

The effects of low dose ketamine on sensory gating, neuroendocrine secretion and behavior in healthy human subjects

Stratifying the autistic phenotype using electrophysiological indices of social perception

P.130 Bumetanide versus placebo for core symptoms of autism spectrum disorder at 91 days (BAMBI): a single-centre, double-blinded, patient-randomized, placebo-controlled, phase-2-trial

Resting state-EEG connectivity and machine learning: towards improved treatment response predictions in psychiatry

P.4.11 Bumetanide in Autism Medication and Biomarker (BAMBI) study: Medication response profiles

Suchergebnisse filtern